In this issue:
TAK-875 vs. placebo/glimepiride in type 2 diabetes
High-protein vs. highcarbohydrate diets
Macronutrients and bodyfat in high-risk Māori
Glucose self-monitoring in noninsulin-treated type 2 diabetes
Basal-bolus vs. sliding-scale insulin for inpatients
Active living programmes for obesity in clinical settings
White rice and type 2 diabetes risk
Satiety and postprandial intranasal insulin
Aspart/detemir mixture pharmacodynamics
Cognitive function and hypoglycaemia
Please login below to download this issue (PDF)